Anti-Human IL31RA Recombinant Antibody
-
产品编号
YR1365
-
别名
科研级 Nemolizumab ( 奈莫利珠单抗 ), Anti-IL31RA Recombinant Antibody, Research Grade Nemolizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Nemolizumab ( 奈莫利珠单抗 ), Anti-IL31RA Recombinant Antibody, Research Grade Nemolizumab |
Catalog Number | YR1365 |
Molecular Name | Nemolizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG2 Kappa |
Formulation | PBS, pH7.5 |
Background | Nemolizumab is an experimental drug for the treatment of itching in people with atopic dermatitis. It is a monoclonal antibody that blocks the interleukin-31 receptor A. Results of a Phase II clinical trial were published in March 2017. |
CAS Number | 1476039-58-3 |
Application | ELISA, IHC, FCM, IP, IF, FuncS |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | IL31RA[Homo sapiens] |